Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China flag China · Delayed Price · Currency is CNY
10.72
+0.05 (0.47%)
Sep 8, 2026, 11:29 AM CST

Shanghai No.1 Pharmacy Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
329.09322.59436.42400.03504.93262.28
Short-Term Investments
-98.0485.6266.2940-
Trading Asset Securities
29.281.0315.3830.15220.29-
Cash & Short-Term Investments
358.37421.67537.41496.47765.22262.28
Cash Growth
-28.10%-21.54%8.25%-35.12%191.75%-48.51%
Accounts Receivable
199.83189.88190.15247.57238133.56
Other Receivables
55.5746.9730.423.3127.131.32
Receivables
255.39236.85220.55270.88265.1164.87
Inventory
362.03354.94336.32332.23334.75214.5
Prepaid Expenses
-7.159.393.520.780.44
Other Current Assets
71.8936.4223.3314.1331.2920.59
Total Current Assets
1,0481,0571,1271,1171,397662.69
Property, Plant & Equipment
222.72253.56260.88215.36181.09167.98
Long-Term Investments
285.69358.86342.74322.45252.47184.14
Other Intangible Assets
35.5836.4638.9341.6743.8346.33
Long-Term Deferred Tax Assets
29.7426.7624.3526.3935.9912.07
Long-Term Deferred Charges
22.5224.5720.5816.2814.439.28
Other Long-Term Assets
255.31264.09165.58123.78114.15251.97
Total Assets
1,8992,0211,9801,8632,0391,334

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
483.32454.1384.14398.59363.69314.8
Accrued Expenses
10.7624.3526.5127.0932.5715.02
Short-Term Debt
-49.995.58101.05320.28-
Current Portion of Leases
-63.4863.9858.3449.0538.94
Current Income Taxes Payable
-1.260.910.2737.335.93
Current Unearned Revenue
4.593.555.365.7125.532.71
Other Current Liabilities
127.3869.8571.6875.7497.9166.64
Total Current Liabilities
626.05666.49648.15676.79926.37444.04
Long-Term Leases
82.86107.82115.56107.2488.3363.08
Long-Term Unearned Revenue
11.2711.511.9712.4411.311.68
Pension & Post-Retirement Benefits
-2.392.52.42--
Long-Term Deferred Tax Liabilities
46.0962.2557.4855.8354.3437.34
Other Long-Term Liabilities
2.37---0.070.4
Total Liabilities
768.65850.46835.66854.721,080556.54

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
223.09223.09223.09223.09223.09223.09
Additional Paid-In Capital
65.5365.5365.5365.1965.1965.19
Retained Earnings
697.42688.65679.98544.95499.18371.24
Comprehensive Income & Other
134.64184.02167.01168.22164.22111.4
Total Common Equity
1,1211,1611,1361,001951.67770.92
Minority Interest
9.99.588.797.017.017.01
Shareholders' Equity
1,1311,1711,1441,008958.68777.92
Total Liabilities & Equity
1,8992,0211,9801,8632,0391,334

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
82.86221.21275.12266.63457.67102.03
Net Cash (Debt)
275.5200.46262.29229.83307.55160.26
Net Cash Growth
-6.95%-23.57%14.12%-25.27%91.91%-51.34%
Net Cash Per Share
1.240.901.171.031.370.71
Filing Date Shares Outstanding
223.17223.09223.09223.09223.09223.09
Total Common Shares Outstanding
223.17223.09223.09223.09223.09223.09
Working Capital
421.62390.53478.85440.44470.77218.65
Book Value Per Share
5.025.215.094.494.273.46
Tangible Book Value
1,0851,1251,097959.77907.85724.58
Tangible Book Value Per Share
4.865.044.924.304.073.25
Buildings
-101.59105.1989.3494.7694.76
Machinery
-27.3626.9626.522626.32
Construction In Progress
-7.785.741.741.432.24